Springer, one of the leading publishers in the fields of science, technology and medicine, has signed a co-publishing agreement with the Indian Association of Surgical Oncology (IASO), to launch the society’s official publication, the Indian Journal of Surgical Oncology (IJSO). Dr. Vijay Kumar, Secretary of the Indian Association of Surgical Oncology; Dr. K.S. Gopinath, editor of the IIndian Journal of Surgical Oncology; Dr. William F. Curtis, President of Springer Science+Business Media, LLC; and Sanjiv Goswami, Managing Director of Springer India, signed the agreement at Bangalore.

The Indian Journal of Surgical Oncology, a new quarterly, peer-reviewed, multidisciplinary journal, will accept articles on all the specialized areas of oncology that engage surgeons in the treatment and management of cancer. The journal aims to serve as a medium of publication for original scientific work from India, as well as from around the world. Original articles, review articles and other special articles of importance and interest dealing with basic and clinical research will be considered for publication.

Dr. Vijay Kumar, Secretary of the Indian Association of Surgical Oncology, said, “We are pleased to bring out IJSO on behalf of the IASO along with Springer. This journal on surgical oncology will help the Association members to update and augment their studies.”

Dr. Gopinath, editor of the IJSO, said, “This is a unique agreement which will help the talented members of our community disseminate their work through the world-class platform SpringerLink.”

Dr. William F. Curtis, President, Springer Science+Business Media, LLC, said, “The Indian Journal of Surgical Oncology adds an important dimension to our publishing portfolio, joining other key peer-reviewed journals in the area of surgery and oncology.”

“Springer is proud to cooperate with the Indian Association of Surgical Oncology, and is delighted to launch the Indian Journal of Surgical Oncology. We anticipate that this agreement will significantly benefit scholars and researchers of surgical oncology in India. The authors and readers will certainly benefit from Springer’s global presence and our online platform, SpringerLink,” said Sanjiv Goswami, Managing Director of Springer India.

The Indian Journal of Surgical Oncology will be published both electronically and in print. The journal will include Cross Reference Linking, alert services, and Online First™, a feature by which articles are published online before they appear in print. Springer will also implement the online author submission system, Editorial Manager. This system allows the peer-review process to be handled faster, resulting in the speedy publication of the articles.

Source:
Joan Robinson

Springer

Nearly 90 per cent of people in the UK back proposals to stop under 18s from using sunbeds according to a new survey by Cancer Research UK.

The results also show that 90 per cent of people want all sunbed salons to be staffed at all times. And 91 per cent want salons to provide health information to all users making sure they are aware of the health risks of using sunbeds.

The survey* - carried out by YouGov - questioned more than 2000 people from across the UK.

Sarah Woolnough, Cancer Research UK’s head of policy, said: “These results show the overwhelming support from the public for laws to be introduced to ensure that sunbeds are properly regulated and that people are aware of the dangers of using sunbeds.

“Cancer Research UK is calling for England, Northern Ireland and Wales to follow in the footsteps of Scotland and stop under 18s from using sunbeds, close salons that aren’t supervised by trained staff and ensure information about the risks of using sunbeds is given to all customers.

“The rates of malignant melanoma - the deadliest form of skin cancer - are rapidly rising in the UK and experts believe that, along with binge tanning on foreign holidays, using sunbeds is one of the main reasons. Legislation would be a fantastic step in the right direction to help prevent people developing the disease.

“This survey follows the COMARE report which categorically states that there are no health benefits from using sunbeds. And with the huge public support revealed in these latest results the government should act now.”

Notes

*All figures, unless otherwise stated, are from YouGov Plc. Total sample size was 2053 adults. Fieldwork was undertaken between 3rd - 6th July 2009. The survey was carried out online. The figures have been weighted and are representative of all UK adults (aged 18+).

To what extent you support or oppose restricting the use of sunbeds in salons to over-18s only?

Strongly support: 64%
Support: 23%
Oppose: 3%
Strongly oppose: 1%
Don’t know: 8%

To what extent you support or oppose measures to ensure that all sunbed salons are staffed so that customers are shown how to use the equipment and sunbed use is supervised?

Strongly support: 65%
Support: 25%
Oppose: 1%
Strongly oppose: 1%
Don’t know: 8%

To what extent you support or oppose ensuring that sunbed salons provide accurate health information about the risks of sunbed use?

Strongly support: 68%
Support: 23%
Oppose: 1%
Strongly oppose: 1%
Don’t know: 7%

To what extent you support or oppose government-funded public awareness campaigns to highlight the link between UV exposure and skin cancer and to make people aware of the risks of sunbed use?

Strongly support: 40%
Support: 36%
Oppose: 8%
Strongly oppose: 5%
Don’t know: 10%
Legislation

In Scotland sunbed legislation has been passed by the Scottish Parliament and will be implemented at the end of the year which Cancer Research UK welcomes.

For more information about SunSmart visit: http://www.sunsmart.org.uk

Skin Cancer Facts

The most common kind of skin cancer is non-melanoma skin cancer. More than 80,000 cases are registered each year in the UK but it is estimated that the actual number is at least 100,000.

Around 10000 cases of malignant melanoma are diagnosed each year in the UK. Incidence rates of this form of skin cancer have quadrupled since the 1970s.

Around 2000 people a year in the UK die from malignant melanoma.

Source
Cancer Research UK

THIS month, Cancer Research UK is set to unveil a brand new national television ad campaign to raise awareness and increase donations for vital research into cancer.

For the first time in one of Cancer Research UK’s national television advertisements, the thought provoking ‘Bad Day’ campaign features cancer survivors and patients and focuses on the emotions and realities of being given a cancer diagnosis. Speaking direct to camera and engaging the audience on a personal level, each of the participants helps deliver a message which both recognises the progress made in cancer treatments but also highlights that there is still a long way to go to beat cancer.

Thanks to the continued support of the public, Cancer Research UK has been at the forefront of advances in the prevention and treatment of cancer and is making a significant impact to the lives of all those affected by the disease. In the UK around 300,000 people are diagnosed with cancer every year and it is responsible for one in four of all deaths. Cancer Research UK is dedicated to reducing the number of deaths from cancer and, thanks to the charity’s work; more people are beating cancer than ever before.

Carolan Davidge, director of brand and PR at Cancer Research UK, said: “The phrase ‘I’ve had a really bad day’ is often thrown around, but our new ad campaign really puts things in perspective. Every one of the inspirational people featured in the ad is either a cancer survivor or cancer patient, and each of them has experienced first hand the truly ‘bad day’ which is played out in the ad. We have chosen real people over actors to emphasise that cancer is not something which happens to ‘other people’, it is around us every day whether that be personally or through family and friends.

“The sad fact about cancer is that one in three of us will be diagnosed at some point in our lives. Cancer Research UK is leading the way in finding new ways to prevent, diagnose and treat cancer and is dedicated to beating the disease. Cancer survival rates have doubled in the last thirty years and our work has been at the heart of that progress.”

Testicular cancer survivor, Darren Couchman, age 36 from Essex, is one of the people who appears in the ad. Darren said: “Thanks to the work of Cance